Bal Pharma Limited (BALPHARMA) Stock Statistics & Valuation Metrics

Bal Pharma Limited has a market cap or net worth of ₹1.60B. The enterprise value is ₹3.01B.

Bal Pharma Limited has 15,920,872 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bal Pharma Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 11.85%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Bal Pharma Limited had revenue of 3.03B and earned 72.15M in profits. Earnings per share was 4.95.

In the last 12 months, operating cash flow was 59.25M and capital expenditures 0.00, giving a free cash flow of 59.25M billion.

Bal Pharma Limited pays an annual dividend of ₹1.2, resulting in a dividend yield of 1.19%

Bal Pharma Limited upcoming earnings date is ―, ―.

Bal Pharma Limited as a current ratio of 1.07, with Debt / Equity ratio of 194.29%

In the past 12 months, Bal Pharma Limited has paid -20.99M in taxes.

Bal Pharma Limited EV to EBITDA ratio is 4.48, with an EV/FCF ratio of -9.78.

Bal Pharma Limited has ₹261.56M in cash and marketable securities with ₹1.55B in debt, giving a net cash position of ₹1.29B billion.

Gross margin is 36.35%, with operating margin of 6.53%, and net profit margin of 2.38%.

The average price target for Bal Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―